Neuroinflammation predicts disease progression in progressive supranuclear palsy. (2021)
Attributed to:
A new noradrenergic strategy to treat Impulsivity in Progressive Supranuclear Palsy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/jnnp-2020-325549
PubMed Identifier: 33731439
Publication URI: http://europepmc.org/abstract/MED/33731439
Type: Journal Article/Review
Volume: 92
Parent Publication: Journal of neurology, neurosurgery, and psychiatry
Issue: 7
ISSN: 0022-3050